Corpus ID: 40059760

Effects of Dintrato(1,2-diaminocyclohexane)platinum (NSC 239851) On murine myeloma and hemopoietic precursor cells.

@article{Ogawa1976EffectsOD,
  title={Effects of Dintrato(1,2-diaminocyclohexane)platinum (NSC 239851) On murine myeloma and hemopoietic precursor cells.},
  author={Makio Ogawa and Glen R. Gale and Sandra J. Meischen and Vesselina Cooke},
  journal={Cancer research},
  year={1976},
  volume={36 9 pt.1},
  pages={
          3185-8
        }
}
We studied the effects of dinitrato (1,2,-diaminocyclohexane)platinum (NSC 239851) on murine myeloma Adj. PC-5 and hemopoietic precursor cells. The median survival time of tumor-bearing mice was significantly affected by i.p. injections of this agent. While 14 mg/kg was a toxic dose, as little as 2 mg/kg prolonged the survival for over 100 days. When cells from normal marrow and actively regenerating marrows were exposed to the agent in culture tubes, washed, and assayed for the surviving… Expand
5 Citations
Resistance against cis-dichlorodiammineplatinum in cultured cells with a high content of metallothionein.
TLDR
It is probable that endogeneously synthesized MT contributes to the resistance against cis-DDP, and three- to fourfold increase of total sulfhydryl content in the resistant strains was accounted for by MT. Expand
Chapter 13. Antineoplastic Agents
Publisher Summary Some important cancer chemotherapeutic agents history, development, mechanism of action, pharmacology, and clinical status are discussed in this chapter. LevorotatoryExpand
The mechanism of action of antitumor platinum compounds.
TLDR
The structure–activity relationships discussed in this chapter indicates that platinum complexes superior to those initially described will become available for clinical use. Expand
Antitumor Platinum Compounds
As a consequence of a classic case of serendipity in science a range of platinum coordination complexes were demonstrated to have potent antitumor action against Sarcoma 180 and Leukemia L1210Expand
Treatment of plasma cell myeloma.
TLDR
General features of the disease, the immuno­ globulin class ofM-protein, clinical manifestations related to the total body myeloma cell number, and renal function have all been found to influence, prognosis. Expand